New diabetes clinical trial: Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents

Published on: February 27, 2020 at 10:30PM
Condition:   Type2 Diabetes Mellitus
Interventions:   Drug: Glucophage 500Mg Tablet;   Drug: Acarbose Tablets;   Drug: Sitagliptin tablet;   Drug: Dapagliflozin Tablet;   Drug: Pioglitazone Tablets;   Drug: Glimepiride Tablets
Sponsors:   Peking Union Medical College Hospital;   Chinese Academy of Sciences
Not yet recruiting
https://ift.tt/2PwgLn3